Home » Topics » Regulatory » Patents

Patents
RSS

New ACSS2 inhibitors discovered at Metabomed

Dec. 7, 2021

Shanghai Litedd presents new nuclear receptor RORgammaT antagonists

Dec. 7, 2021

Jiangsu Protelight Pharmaceutical & Biotechnology patents amino acid derivatives

Dec. 7, 2021

BioWorld MedTech Patent Highlights: Week 47

From Current Patent Gazette

Dec. 3, 2021

BioWorld MedTech presents Patent Highlights, an excerpt of the most important med-tech patents from this week's Cortellis Patents Gazette.

J2H Biotech synthesizes new compounds for liver cancer

Dec. 3, 2021

Bristol Myers Squibb synthesizes new galectin-3 inhibitors

Dec. 3, 2021

PMV Pharmaceuticals identifies new TP53 mutant stabilizers

Dec. 3, 2021

Merck & Co. divulges coagulation factor XIa inhibitors

Dec. 3, 2021

Accutar Biotechnology patents EGFR and/or HER2 inhibitors

Dec. 3, 2021

Shanghai Zheye Biotechnology divulges new SGLT-1 inhibitors

Dec. 2, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...